Month: November 2012

Poverty versus patenting in India – round two

Earlier this year the first compulsory license, regarding the anti-cancer drug Sorafenib, was granted in India. (See previous blog

Read more...

Is it worth the effort to appeal a decision made by the DKPTO?

Danish case law regarding patents shows that in a vast majority of cases, the Danish Board of Appeal (BoA)

Read more...

Elementary, my dear Watson

When reading a novel the other day, I came across a statement by a consulting detective. “What one man

Read more...

Mobile Sliding Menu